Literature DB >> 24625234

Improving cervical cancer screening rates in an urban HIV clinic.

Sara L Cross1, Sanaa H Suharwardy, Phani Bodavula, Kenneth Schechtman, E Turner Overton, Nur F Onen, Michael A Lane.   

Abstract

Human immunodeficiency virus (HIV)-infected women are at increased risk of invasive cervical cancer; however, screening rates remain low. The objectives of this study were to analyze a quality improvement intervention to increase cervical cancer screening rates in an urban academic HIV clinic and to identify factors associated with inadequate screening. Barriers to screening were identified by a multidisciplinary quality improvement committee at the Washington University Infectious Diseases clinic. Several strategies were developed to address these barriers. The years pre- and post-implementation were analyzed to examine the clinical impact of the intervention. A total of 422 women were seen in both the pre-implementation and post-implementation periods. In the pre-implementation period, 222 women (53%) underwent cervical cancer screening in the form of Papanicolaou (Pap) testing. In the post-implementation period, 318 women (75.3%) underwent cervical cancer screening (p < 0.01). Factors associated with lack of screening included fewer visits attended (pre: 4.2 ± 1.5; post: 3.4 ± 1.4; p < 0.01). A multidisciplinary quality improvement intervention was successful in overcoming barriers and increasing cervical cancer screening rates in an urban academic HIV clinic.

Entities:  

Keywords:  HIV/AIDS; cervical cancer screening; health maintenance; quality improvement

Mesh:

Year:  2014        PMID: 24625234      PMCID: PMC4065211          DOI: 10.1080/09540121.2014.894610

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  28 in total

1.  Cervical cancer screening among U.S. women: analyses of the 2000 National Health Interview Survey.

Authors:  Maria Hewitt; Susan S Devesa; Nancy Breen
Journal:  Prev Med       Date:  2004-08       Impact factor: 4.018

2.  Individual-, neighborhood-, and state-level socioeconomic predictors of cervical carcinoma screening among U.S. black women: a multilevel analysis.

Authors:  Geetanjali D Datta; Graham A Colditz; Ichiro Kawachi; S V Subramanian; Julie R Palmer; Lynn Rosenberg
Journal:  Cancer       Date:  2006-02-01       Impact factor: 6.860

3.  Screening HMO women overdue for both mammograms and pap tests.

Authors:  Barbara G Valanis; Russell E Glasgow; John Mullooly; Thomas M Vogt; Evelyn P Whitlock; Shawn M Boles; K Sabina Smith; Teresa M Kimes
Journal:  Prev Med       Date:  2002-01       Impact factor: 4.018

4.  Impact of audit on preventive measures.

Authors:  D M Fleming; M S Lawrence
Journal:  Br Med J (Clin Res Ed)       Date:  1983-12-17

5.  Screening for cervical cancer in HIV-infected women receiving care in the United States.

Authors:  M D Stein; W E Cunningham; T Nakazono; B J Turner; R M Andersen; S A Bozzette; M F Shapiro
Journal:  J Acquir Immune Defic Syndr       Date:  2001-08-15       Impact factor: 3.731

6.  Achievements in public health. Reduction in perinatal transmission of HIV infection--United States, 1985-2005.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2006-06-02       Impact factor: 17.586

7.  Computerized reminders to encourage cervical screening in family practice.

Authors:  I McDowell; C Newell; W Rosser
Journal:  J Fam Pract       Date:  1989-04       Impact factor: 0.493

8.  Promoting cancer screening. A randomized, controlled trial of three interventions.

Authors:  S J McPhee; J A Bird; C N Jenkins; D Fordham
Journal:  Arch Intern Med       Date:  1989-08

9.  Increasing cervical cancer screening among underserved women in a large urban county health system: can it be done? What does it take?

Authors:  Roshan Bastani; Barbara A Berman; Thomas R Belin; Lori A Crane; Alfred C Marcus; Kiumarss Nasseri; Nikki Herman-Shipley; Sol Bernstein; Carole E Henneman
Journal:  Med Care       Date:  2002-10       Impact factor: 2.983

10.  The safety net: a cost-effective approach to improving breast and cervical cancer screening.

Authors:  Thomas M Vogt; Andrew Glass; Russell E Glasgow; Pierre A La Chance; Edward Lichtenstein
Journal:  J Womens Health (Larchmt)       Date:  2003-10       Impact factor: 2.681

View more
  3 in total

1.  A Randomized Trial of Human Papillomavirus Self-Sampling as an Intervention to Promote Cervical Cancer Screening Among Women With HIV.

Authors:  Jeanne Murphy; Hayley Mark; Jean Anderson; Jason Farley; Jerilyn Allen
Journal:  J Low Genit Tract Dis       Date:  2016-04       Impact factor: 1.925

2.  Prevalence and correlates of cervical HPV infection in a clinic-based sample of HIV-positive Hispanic women.

Authors:  A P Ortiz; V Tamayo; A Scorsone; M Soto-Salgado; I Febo; P Piovanetti; H L Venegas-Ríos; Y Yamamura; C Zorrilla
Journal:  Papillomavirus Res       Date:  2017-06-19

3.  Knowledge, attitude, and practice of cervical cancer screening among women living with HIV in the Kilimanjaro region, northern Tanzania.

Authors:  Faustini C Kimondo; Happiness D Kajoka; Meshack R Mwantake; Caroline Amour; Innocent B Mboya
Journal:  Cancer Rep (Hoboken)       Date:  2021-03-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.